Suninflam Epilepsy
Suninflam Epilepsy Purpose of the study? This is a dose escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of SIF001, a monoclonal antibody with the potential to treat epilepsy. Detailed Description Nonclinical studies including disease animal model studies and toxicological studies indicate that SIF001 has the potential to be a therapeutic agent for […]
Suninflam Epilepsy Read More »